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Treatment of soybean lipoxygenase-l (SLO) with phenylhydrazine (PH) induced inactivation and a maximum (350 nm) 
in the absorption spectrum of the enzyme. To detach the product having this absorption maximum, proteolysis was re- 
quired. The product appeared to be the C(5) phenylhydrazone of pyrroloquinoline quinone (PQQ). Quantification 
showed that one covalently bound PQQ is present per enzyme molecule. Inspection of published spectroscopic data leads 
to the conclusion that the established cofactor of SLO, Fe, present as one ion per enzyme molecule, interacts with PQQ, 
the latter functioning as a terdentate ligand for the Fe ion (the N atom and COOH group of the quinoline ring together 
with the hydrated C(5) carbonyl group). If it is assumed that the substrate has two sites of interaction with this two- 
cofactor complex, namely with the Fe ion and the C(5) carbonyl group of PQQ, the electron-relay system generated very 
well explains the reported mechanistic features as well as inhibition effects of substrates with extended conjugation sys- 
tems. The finding of PQQ in SLO is an additional indication that this cofactor is very versatile with respect to involvement 
in different types of redox reaction. A further implication might be that PQQ has been overlooked in other well-known 
enzymes with an established cofactor but where the presence of this cofactor is unable to explain the mechanistic and 
spectroscopic features. 
Lipoxygenase-I; Pyrroloquinoline quinone; Hydrazine; Cofactor; Quinoprotein; Iron-containing enzyme 
1. INTRODUCTION 
Enzymatic lipoxygenation is a process of con- 
siderable biological importance, since it is involved 
in the biosynthesis of regulators like leukotrienes, 
prostaglandins and lipoxins. The process is 
typified by regio- and stereo-specific onversion of 
arachidonic acid into the corresponding 155 
peroxide by means of soybean lipoxygenase (EC 
1.13.11.12) (SLO). Although the enzyme was first 
crystallized 40 years ago and has meanwhile been 
investigated using several sophisticated techniques, 
a coherent picture, combining the structural and 
mechanistic information, is still lacking. The con- 
clusion which can be derived from some recent 
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reviews [1,2] is that the enzyme is an unelucidated, 
unique iron-protein. 
It is generally accepted that non-haem iron is the 
only cofactor in SLO (present in a ratio of 1 Fe per 
enzyme molecule). Despite the fact that the nature 
of the residues involved in liganding is unknown, 
attempts have been made to interpret the (unusual) 
ESR and absorption spectroscopy parameters and 
from this to propose a mechanism [1,2]. For this 
purpose the assumption is made that Fe is involved 
in hydrogen abstraction from the substrate as well 
as in addition of dioxygen to the free radical sub- 
strate intermediate (fig. 1A). Obviously, to per- 
form this dualistic function, changes in the valency 
of Fe are required. From studies with mechanism- 
based inhibitors, however, another view has been 
proposed [3] in which this valency change is not re- 
quired. Proton abstraction, catalyzed by an (very 
strong) unspecified, basic group in the active site, 
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Fig.1. Proposed mechanisms for SLO: (A) the free radical 
mechanism [1,2]; (B) the organo-iron mechanism [3]. 
is supposed to occur with concurrent electrophilic 
attack of Fe on the substrate (fig.lB). It will be 
clear that these views are contradictory, but as long 
as real insight into the structure and functioning of 
the Fe centre is lacking, both mechanisms can be 
brought into agreement with the data available 
from the literature. 
Until recently, a similar situation existed with 
respect o dopamine &hydroxylase (EC 1.14.17.1). 
This enzyme has long been considered as a colour- 
less copper-protein, the Cu being involved as the 
only cofactor operating in the hydroxylation pro- 
cess. It now appears that this picture is incorrect, 
the enzyme also containing covalently bound pyr- 
roloquinoline quinone (PQQ), probably operating 
as an additional cofactor in the catalytic cycle [4]. 
The fact that the presence of PQQ has been over- 
looked for so long in this well-known enzyme 
might indicate that the same has occurred in other 
cases where a cofactor is known but its presence is 
unable to explain the essential structural and 
mechanistic features of the enzyme in an adequate 
way. As may be clear from the foregoing, SLO 
seemed a good candidate to check the validity of 
this hypothesis. 
All eucaryotic quinoproteins (PQQ-containing) 
discovered so far contain PQQ in covalently bound 
form. A proven, reliable way to demonstrate the 
presence of the cofactor in such a case is to apply 
the so-called ‘hydrazine method’ [5], derivatizing 
PQQ in situ to a reasonably stable adduct before 
protein hydrolysis is carried out. Since SLO 
becomes irreversibly inhibited with phenyl- 
hydrazine (PH) (but the product is unknown) [6], 
this could be interpreted in favour of the hypo- 
thesis and thus of the feasibility of the hydrazine 
method for this enzyme. 
2. MATERIALS AND METHODS 
2.1. Purification of SLO 
Lipoxygenase from Sigma (type 1) was further purified on 
DEAE-Sepharose (Pharmacia) followed by HPLC gel filtration 
on an SI 300 polyol column (Serva). The amount of purified 
SLO was determined using the specific absorption coefficient 
determined by Petersson et al. [7] (A$&?,,,, = 1.6). 
2.2. Inhibition with PH and characterization of the product 
Derivatization of the cofactor in SLO with PH and isolation 
of the adduct were essentially as described [5], under the follow- 
ing conditions: to a solution (14 ml) of SLO (3 1 mg) in 0.1 M 
borate buffer, pH 10.0, 16 ,~l of a 0.1 M solution of PH in con- 
centrated H3POb/ethanol (1 : 1, v/v) [8] was added; the mixture 
was incubated at 40°C for 16 h under air; proteolysis was per- 
formed by addition of 16 mg pronase E (Boehringer, Mann- 
heim) and incubation at 40°C for 6 h. Separation on a Seppak 
cartridge, HPLC (on a 4 pm CIS RCM cartridge) of the isolated 
adduct, its transformation into PQQ, the preparation of the 
model hydrazone from PQQ and PH, and the determination of 
PQQ concentrations were all performed as in [5]. 
2.3. Enzyme assay 
SLO activity was determined by measuring the increase in ab- 
sorbance at 234 nm of the hydroperoxide product, formed from 
linoieic acid (Sigma, - 99% free acid) according to Galey et al. 
191. Activities were calculated as pmol hydroperoxide product 
formed/min using a molar extinction coefficient for the hydro- 
peroxide product of 25 000 M-' . cm-’ [9]. 
2.4. Iron determination 
Quantitative determination of Fe’+ in SLO was performed 
spectrophotometrically according to Massey [lo]. Fe’+ concen- 
trations were calculated using a molar extinction coefficient of 
11000 M-‘.cm-’ [lo]. 
3. RESULTS 
The indicated purification steps provided an 
SLO preparation with a specific activity of 
188 pm01 hydroperoxide product formed - 
min- ’ . mg- ’ (protein), a value comparable with 
that found by others for a preparation considered 
to be homogeneous [ll]. Similarity and 
homogeneity were also apparent from the Fe con- 
tent found (0.91 Fe’+ per enzyme molecule) and 
that reported [ 111. No heterogeneity in activity was 
observed during the chromatographic steps so that 
the enzyme preparation only contains lipoxy- 
genase-1 [7]. 
The SLO preparation had a structureless absorp- 
tion spectrum (fig.2). Inhibition with PH induced 
a maximum at 350 nm (fig.2), a phenomenon 
which has been observed for several copper-quino- 
proteins [4,5]. Acidification of inhibited enzyme to 
19.5 
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Fig.2. Absorption spectra of SLO (2.2 mg/ml in 0.1 M borate 
buffer, pH 10.0) before (-) and after (-- -) derivatization 
with PH. 
pH 2.0 did not release a product with this absorp- 
tion maximum, but proteolysis, followed by 
acidification, did (as evident from adsorption to 
and elution from the Seppak cartridge). Since all 
chromatographic and spectral properties of the 
product (not shown) were identical to those of the 
C(S)-hydrazone of PQQ and PH [S], and the 
product could be converted into PQQ, it is con- 
cluded that the 350 nm product is the C(5)- 
hydrazone of PQQ and PH. Quantification in- 
dicated that 0.88 PQQ is present per enzyme 
molecule. 
Although immediate inhibition occurred, for- 
mation of the so-called azo compound [5] was not 
observed. Formation of the hydrazone in the en- 
zyme required the usual (long) incubation time, 
but in contrast to the copper-quinoproteins [4,5] 
proceeded efficiently under air and did not require 
high oxygen tensions. 
4. DISCUSSION 
4.1. Product identification: evidence for PQQ 
The spectroscopic data on the inhibited enzyme 
(fig.2) and the spectroscopic and chromatographic 
data of the isolated product indicate that PH in- 
hibition leads to the formation of the C(5)- 
hydrazone of PQQ and PH in SLO. Since product 
release required protein hydrolysis, PQQ is 
covalently bound to the protein, probably via an 
amide bond. From the fact that the enzyme 
preparation was homogeneous and PH inhibition 
has been observed by others [6], it is concluded 
that the finding is not adventitious but that PQQ 
is a real constituent of SLO. A ratio of 0.88 PQQ 
per enzyme molecule was determined, indicating 
that the monomeric enzyme contains 1 PQQ and 
1 Fe. PH inhibition of SLO has been intensively 
studied [6]. Although product analysis was not car- 
ried out, it was demonstrated that phenyldiazene, 
formed from PH under oxidative conditions, is the 
genuine inhibitor. Furthermore, it was suggested 
that phenyldiazene is degraded into a phenyl 
radical which attacks SLO [6]. Although it now ap- 
pears that the suggestion is incorrect, the diazene 
could indeed be the inhibiting species, since no azo 
compound was formed and hydrazone formation 
required aerobic conditions, in contrast with amine 
oxidoreductases where the azo compound is form- 
ed under anaerobic conditions, suggesting that the 
hydrazine itself is the inhibiting species [4,5]. Since 
the latter enzymes occur in their oxidized form but 
(as discussed below) native SLO seems to be in a 
reduced form, the difference is comprehensible. 
4.2. Accordance with spectroscopic data 
After ascertaining that PQQ is a constituent of 
the enzyme, the question can be raised as to 
whether spectroscopic data are in accordance with 
this, and more intriguing, whether there is any in- 
dication for changes in its redox state, pointing to 
a function as cofactor. To answer this, the spectro- 
scopic properties of the enzyme forms of SLO 
should be inspected and compared with those of 
PQQ, its biologically relevant redox forms and 
derivatives (see fig.3 for structures), and establish- 
ed quinoproteins. 
Before discussing the particular enzyme forms, 
it is necessary to comment on the overall spectro- 
scopic properties. A remarkable feature of the ab- 
sorption spectra is the structureless, broad band 
belonging to the non-protein chromophores, ex- 
tending from 300 to 700 nm and having low 
molecular absorbances. ESR spectra suggest hat 
the enzyme forms are mostly homogeneous with 
respect o the redox state of the Fe. Since the redox 
forms of PQQ as well as of Fe have well-defined 
absorption bands, it must be assumed that more 
than two chromophores exist in the preparation of 
the enzyme form, this phenomenon being related 
to the occurrence of either several redox forms of 
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Fig.3. Redox forms and adducts of PQQ. The following ad- 
ducts are mentioned in the text: R, CN, cyanide adduct; R, O- 
CH2-CH2, ethanol adduct; R, OH, hydrated PQQ. 
PQQ or close interaction of the two cofactors so 
that new species are formed, leading to overlap of 
absorption bands. 
4.3. Native SLO 
This is an ESR-silent enzyme form showing the 
characteristic broad absorption band but with 
slightly visible shoulders at 330 and 400 nm [12] 
and a weak circular dichroism (CD) band around 
330 nm [ 131. From mechanistic and ESR spectro- 
scopic features it is generally assumed that Fe is in 
an ESR-silent Fe2+ form [14,15]. Treatment with 
NO leads to the characteristic ESR spectrum of an 
Fe2+-NO complex, the signal showing changes in 
the range pH 9-10 [16]. Also, addition of primary 
alcohols has a strong effect on the signal and these 
compounds have a remarkably high affinity for the 
enzyme, clearly not by direct binding to Fe2+. It is 
known (171, however, that alcohols, cyanide, and 
Hz0 easily form reversible adducts with PQQ at 
the C(5) position (fig.3). Moreover, the pyridine 
carboxylic acid moiety of PQQ is well suited for 
binding of an Fe ion. In fact, pyridine 2,4-di- 
carboxylic acid is an excellent Fe chelator and an- 
tagonist of the iron-protein, prolyl 4-hydroxylase 
(EC 1.14.11.2) [18]. An even better (terdentate) 
coordination is possible if the C(5) carbonyl group 
of PQQ is incorporated as ligand, in agreement 
with the strong binding of the Fe ion to SLO. The 
spectroscopic data can, therefore, be reconciled 
with a complex of Fe2+ and PQQ in the configura- 
tion given in fig.4 [additional evidence for this 
structure derives from model studies of PQQ and 
metal ions (Jongejan, J.A., unpublished) and from 
arguments provided in the discussion of the other 
Fig.4. The complex of PQQ and the Fe ion in SLO and the 
mode of binding of NO and ethanol to the complex. 
enzyme forms]. The OH group at the C(5) position 
of hydrated PQQ (having a pK, value between 9 
and 10, unpublished) could explain the pH effect 
on the ESR spectrum of the NO-treated enzyme. 
Indeed, this phenomenon is not observed if the OH 
group is replaced by adding a small amount of 
ethanol to the enzyme [16]. 
Although the complex is proposed to consist of 
Fe’+ and PQQ, in fact the redox state of the consti- 
tuent species cannot be indicated and formally the 
system could also be described as a diamagnetic 
complex of Fe3+ and PQQH’. This explains why 
the characteristic absorption band of one of the 
PQQ redox species is not observed and the re- 
quirements of inhibition with PH, suggesting that 
PQQ is in a reduced state. It could also be possible 
that the preparation is not homogeneous with 
respect to either conformation (leading to dif- 
ferences in or absence of interactions of PQQ and 
Fe’+) or the redox state of PQQ. In view of the 
weak CD band at 330 nm, a small amount of the 
fully reduced form, PQQH2 (A,,,,, PQQH2 is at 
310 nm, leading to an absorption band in some 
quinoproteins at 335-340 nm [ 191) could indeed be 
present. The same applies to the semiquinone 
form, PQQH’, since a weak ESR signal at g = 2 
has frequently been reported (this has been as- 
cribed to metal ion contamination, but in view of 
the fact that several quinoproteins contain 
PQQH’, the g = 2 signal of SLO should be careful- 
ly inspected in the future). The slight heterogenei- 
ty, as suggested here, is in accordance with the 
broad absorption band and the ESR data, in- 
dicating some variability in ligand configuration of 
the Fe ion. 
4.4. Yellow SLO 
This enzyme form is obtained by mixing native 
enzyme with a stoichiometric amount of product, 
e.g. the hydroperoxide of linoleic acid. This treat- 
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ment produces active enzyme and a general in- 
crease in absorbance in the 330-450 nm region, 
most significantly around 350 nm [ 121. Two bands 
are induced in the CD spectrum, namely at 345 and 
425 nm [ 131. A maximum around 425 nm has been 
reported for several (ferric) iron-proteins and is in 
accordance with the observed g = 6 ESR signal 
[20], the intensity accounting for about 75% of the 
iron present in the protein (perhaps the remaining 
part still existing in the diamagnetic omplex of the 
native form). The band at 345-350 nm could 
originate from (uncomplexed) PQQH’, since an 
identical band has been found for the semiquinone 
form of methanol dehydrogenase [2 11. Another in- 
dication that some PQQH’ occurs in uncomplexed 
form, might be the weak g = 2 ESR signal in this 
enzyme form [22] (although this has been implicit- 
ly ascribed to decomposition products of the 
hydroperoxide, it is rather narrow in accordance 
with a top-top value of 0.6 mT for PQQH’ [23]). 
Also, for this enzyme form, the effects of 
alcohol addition were investigated [20]. From the 
line broadening due to binding, as measured by 
‘H-NMR spectroscopy, it was calculated that the 
protons at the Cl and C2 of ethanol are rather 
remote from the Fe3+ centre (at 5 and 6 A, respec- 
tively). Cyanide also has strong effects on the ESR 
spectrum but experiments [20] with 13CN showed 
that cyanide is definitely not bound to the Fe3+. All 
these data support the idea that the main yellow 
enzyme species consists of a complex of Fe3+ and 
PQQ with a structure as depicted in fig.4. 
4.5. Purple enzyme form 
On treating native enzyme with an excess of 
hydroperoxide product [25], a new maximum is 
generated at 578 nm, concomitant with a signal at 
g = 4.2 in the ESR spectrum [since there is also an 
increase in absorbance in the 350-400 nm region 
and the amount of ESR-visible Fe increases to 90% 
(consisting of 80% g = 6 and 10% g = 4.2 signal), 
this is another indication that the yellow enzyme 
form is not completely in the Fe3+/PQQ redox 
state]. A band at 580 nm and a double band at 
390/410 nm are seen in the CD spectrum [ 131. An 
identical double band has been observed in the ab- 
sorption spectrum of fully oxidized methanol de- 
hydrogenase and this has been ascribed to PQQ 
occurring as a C(5) adduct in the enzyme [21,27]. 
In view of the unusually high maximum and molar 
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absorption coefficient of the 580 nm band, the Fe 
must be in a special environment, achieved by 
direct binding of the hydroperoxide to either the 
Fe3+ or PQQ at the C(5) position (the latter 
possibility could be responsible for the 
3901410 nm double band). Since only 10% of the 
Fe exists in this state [25], this suggests that the ma- 
jor part of the purple enzyme form contains the 
Fe3+/PQQ couple as described for the yellow en- 
zyme form. 
Although an adequate interpretation of the spec- 
troscopic data is now possible from the proposed 
complex, this forms only the beginning of their 
assignment. Quantitative studies on the Fe/PQQ 
species in the enzyme and model studies should 
shed more light on the exact structure of the com- 
plexes and on heterogeneity. 
4.6. Mechanistic considerations 
Taking the proposed complex (fig.4) and the 
properties of the enzyme forms into account, the 
next question to arise is whether a mechanism can 
be derived with a role of PQQ in the catalytic cy- 
cle. Mechanistic studies strongly suggest that 02 in- 
sertion is preceded by hydrogen abstraction, these 
reactions taking place at different sites of the sub- 
strate molecule in a regio- and stereo-specific way 
[1,2]. Hydrogen abstraction leads to a substrate 
radical from which the hydroperoxide product can 
be formed or to aberrant reactions (e.g. dimeriza- 
tion) if the 02 concentration is too low. Current 
mechanisms [ 1,2] propose the involvement of Fe in 
hydrogen abstraction as well as dioxygenation, 
although it is difficult to see how this dualistic role 
can be performed and high selectivity be achieved 
with only one Fe ion in the enzyme molecule. This 
problem is solved, however, if it is assumed that 
the substrate remains bound to the enzyme 
molecule during the catalytic cycle and that both 
PQQ and Fe are involved in the overall process, so 
that the intermediate is shielded from unspecific 02 
attack and the stereo- and regio-specific reactions 
can proceed in the appropriate way. Since NO 
binds to the Fe ion and substrate competes for the 
same binding site, but 02 does not [16], it is 
reasonable to assume that the oxygen insertion site 
of the substrate molecule is a ligand for Fe but that 
02 binding occurs via another Fe ligand. With this 
in mind, it is easy to see that the other interaction 
of the substrate could occur with the C(5) carbonyl 
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group of PQQ, a site where hydrogen abstraction 
from the substrate is possible. The resulting 
electron-relay system (fig.SA) allows abstraction 
of hydrogen from the substrate with concomitant 
conversion of Fe3+ into Fe2+, the latter being well 
suited to perform 02 insertion (see fig.SB for a ten- 
tative scheme of the steps). 
An essential feature of lipoxygenation is migra- 
tion of the unpaired electron through the substrate 
molecule to the carbon atom where 02 addition oc- 
curs. Using mechanism-based inhibitors with extra 
double bonds, upstream of and in conjugation 
with the double bond where 02 insertion takes 
place, after hydrogen abstraction the unpaired 
electron in the substrate molecule has other 
possibilities to reside. Thus, the dioxygenation step 
becomes more difficult but the probability of 
wrong 02 insertions and reaction of the unpaired 
electron with residues of the enzyme increase. This 
is indeed what has been found [3], 02 insertion oc- 
curring at high oxygen tensions (but mainly at the 
wrong sites) and irreversible inactivation at low 
tensions. Unfortunately, product analysis in in- 
hibited enzyme has been scarcely performed. Using 
an acetylenic fatty acid analogue, it was found that 
yellow enzyme form 1s 5.1 
I 02 
Paa 
F&O2 
5’ 
PaaH’ 
[ 
Paa 
FC3’ - Fez* 1 notw enzyme form 
Fig.5. Hydroperoxidation mechanism of SLO with arachidonic 
acid. The enzyme-substrate complex is depicted in (A) and a 
tentative catalytic cycle in (B). 
inhibition was related to conversion of a 
methionine residue into methionine sulfoxide [26]. 
However, the fact that arachidonic acid conversion 
under anaerobic conditions also leads to irreversi- 
ble inactivation suggests that free radical derange- 
ment might also occur in the substrate moiety 
interacting with the Fe3+/PQQ system so that 
other modes of inactivation could exist. In this 
context, it is interesting to mention the inactivation 
of methanol dehydrogenase by cyclopropanol 
where the free radical, due to ring opening, adds to 
PQQ [27]. Since a similar reaction might occur 
under anaerobic conditions with arachidonic acid 
as a substrate, product analysis might be worth- 
while to substantiate further the involvement of 
PQQ and the mechanism proposed. 
Although the Fe3+/PQQ system is in principle 
also suited for concerted proton abstraction (with 
the deprotonated OH group at the C(5) position of 
PQQ) and electrophilic attack of Fe3+ on the sub- 
strate, as required in the organo-iron mechanism 
[3] (fig.lB), the free radical mechanism seems 
more attractive, since it provides the best explana- 
tions for all features presently known. To substan- 
tiate it further, in view of the participation of 
PQQH’ and substrate radical, extensive ESR 
studies of SLO in the g = 2 region should be per- 
formed. 
4.7. Further implications 
The finding that SLO is a quinoprotein strongly 
supports the notion that the cofactor PQQ is ver- 
satile and ubiquitous as it occurs in dehydro- 
genases, oxidases, hydroxylases and dioxygenases 
and has meanwhile been detected in enzymes pre- 
sent in species from microbes to man. In view of 
their properties, lipoxygenases of mammalian 
organisms, being involved in the route of biosyn- 
thesis of leukotrienes and prostaglandins, might 
also be quinoproteins. Curiously, the already 
established mammalian copper-quinoproteins are 
also involved in biosynthesis or degradation of bio- 
regulators (histamine, polyamines, dopamine). 
The discovery of PQQ in these enzymes might, 
therefore, have an important impact in the field of 
pharmacology. A further consequence of the 
finding is that other well-known enzymes for 
which a cofactor has already been indicated might 
eventually appear to be quinoproteins as well. 
Since PQQ is a versatile chelator (at least 3 sites 
199 
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available) and several precedents exist now 
already, metallo-enzymes should be considered in 
particular. 
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